Deep Dive: Drug Prices and Access to Medicine
Setup
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach for countess ailing people, including many with decent insurance. The industry argues that it needs the revenue for the complex and expensive research that leads to better treatments, but pharmaceutical executives are being pilloried in editorials and Congressional hearings, and consumer groups say marketing and profit are the real drivers of price. What’s behind the cost of drugs? What are the options for people who can’t pay it?
Speakers
-
Kenneth L. DavisPresident and CEO of Mount Sinai Health System -
Alan WeilEditor In Chief, Health Affairs -
Kiah WilliamsCo-Founder and Director, SIRUM -
Lisa GillDeputy Content Editor, Best Buy Drugs, Consumer Reports (Festival Unde... -
Ezekiel EmanuelVice Provost for Global Initiatives, Diane v. S. Levy and Robert M. Le... -
Geoffrey ChaikenCo-Founder and CEO, Blink Health -
Kirsten AxelsenVice President Global Policy, Pfizer (Festival Underwriter)
Explore More
Health
If you're fully vaccinated, are you protected from COVID-19? Will we need booster shots? What's the best way to keep children safe as they return to school? Infectious disease...
From blockchain to back to school and virus-hunting to bridging divides, speakers at the 2021 Aspen Ideas Festival addressed issues in a new kind of world—one touched, and cha...
Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the wor...
Faced with the COVID-19 pandemic, the healthcare industry had to quickly adapt to confront the rapidly evolving challenges facing its patients, customers, and employees. Learn...
As new public health threats brew, we need to ensure there is capacity within our health systems to serve the people of this country. There is a strong business case for readi...
To protect our nation’s health, safety and security, it is vital we hold public health prevention and preparedness as a high priority—as high as our nation’s military defense.
The coronavirus is mutating rapidly at the same time people around the world are getting vaccinated. Will the vaccines protect us from the variants?